| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/13/2005 | US20050008650 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 01/13/2005 | US20050008645 Antibodies Specific For Phosphatase Subunit of LAR |
| 01/13/2005 | US20050008637 Cancer therapy; antiinflammatory agents; autoimmune disease |
| 01/13/2005 | US20050008635 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods |
| 01/13/2005 | US20050008628 Polynucleotide gene expression construction; therapy of diseases caused by damage to excitable tissue; cardiovascular disorders therapy; antidiabetic agents; Parkinson's disease; antiepileptic agents; neurodegenerative agents |
| 01/13/2005 | US20050008626 Removing adipose tissues; controlling concentration of stem cells; congestive heart failure |
| 01/13/2005 | US20050008624 Expansion of renewable stem cell populations |
| 01/13/2005 | US20050008623 In vitro production of dendritic cells from CD14+ monocytes |
| 01/13/2005 | US20050008621 Preadipocyte cell strains and uses therefore |
| 01/13/2005 | DE10208311B4 Vorrichtung und Verfahren zur Kultivierung von Gewebezellen Device and method for the cultivation of tissue cells |
| 01/13/2005 | CA2568859A1 Cytokine variant polypeptides |
| 01/13/2005 | CA2563362A1 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds |
| 01/13/2005 | CA2531367A1 Method of preparing transgenic organism with use of methylation and system therefor |
| 01/13/2005 | CA2531360A1 Methods of producing differentiated hematopoietic cells for treatment of cytopenia |
| 01/13/2005 | CA2531321A1 Rna processing protein complexes and uses thereof |
| 01/13/2005 | CA2531240A1 An endogenous peptide and active subfragments thereof |
| 01/13/2005 | CA2530591A1 Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy |
| 01/13/2005 | CA2530533A1 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
| 01/13/2005 | CA2530490A1 Conditioned matrix compositions for tissue restoration |
| 01/13/2005 | CA2530427A1 Elevation of oil levels in plants |
| 01/13/2005 | CA2530272A1 Antibodies that cross-react with two or more kir2dl nk cell reporters and potentiate nk cell cytotoxicity |
| 01/13/2005 | CA2529578A1 Antibodies for use in increasing bone mineralization |
| 01/13/2005 | CA2529244A1 Rapamycin resistant t cells and therapeutic uses thereof |
| 01/13/2005 | CA2529058A1 Increased t-cell tumor infiltration by mutant light |
| 01/13/2005 | CA2528860A1 Recombinant antibodies and compositions and methods for making and using the same |
| 01/13/2005 | CA2528551A1 Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof |
| 01/13/2005 | CA2528134A1 Tissue scaffold having aligned fibrils, apparatus and method for producing the same, and artificial tissue and methods of use thereof |
| 01/13/2005 | CA2528094A1 Expression vectors for stimulating an immune response to cancer antigens |
| 01/13/2005 | CA2527877A1 Unnatural reactive amino acid genetic code additions |
| 01/13/2005 | CA2524148A1 Mptens as modifiers of the pten/igf pathway and methods of use |
| 01/12/2005 | EP1496364A2 Cloning and expression of gonadotropin-releasing hormone receptor |
| 01/12/2005 | EP1496125A2 Genetic transformation using a PARP inhibitor |
| 01/12/2005 | EP1496119A1 Cell population provided with identification codes and method of screening cell population |
| 01/12/2005 | EP1496118A1 Method of measuring human cyp3a inducibility |
| 01/12/2005 | EP1496112A2 Neutral Proteas (NP) and its use in dissociation of tissues |
| 01/12/2005 | EP1496111A2 Variants of 3-Phosphoglycerate dehydrogenase with reduced inhibition by L-serine and genes encoding the same |
| 01/12/2005 | EP1496110A1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes |
| 01/12/2005 | EP1496109A1 Process for producing cytotoxic lymphocyte |
| 01/12/2005 | EP1496066A1 Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells |
| 01/12/2005 | EP1495330A1 Method of identifying transmembrane protein-interacting compounds |
| 01/12/2005 | EP1495301A2 Devices, methods and systems for collecting material from a breast duct |
| 01/12/2005 | EP1495141A2 Hiv therapeutic |
| 01/12/2005 | EP1495123A1 Erbb3 based methods and compositions for treating neoplasms |
| 01/12/2005 | EP1495122A1 Antiviral therapy on the basis of rna interference |
| 01/12/2005 | EP1495121A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 01/12/2005 | EP1495117A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 01/12/2005 | EP1495114A2 A process for the preparation of stem cells from human muscle tissue and adipose tissue, and stem cells 0btainable by this process |
| 01/12/2005 | EP1495113A2 Stimulation of nerve cell regeneration |
| 01/12/2005 | EP1495112A2 Cell culture medium |
| 01/12/2005 | EP1495111A2 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 01/12/2005 | EP1495108A2 Automated tissue engineering system |
| 01/12/2005 | EP1495053A2 Angiopoietin-2 specific binding agents |
| 01/12/2005 | EP1495051A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 01/12/2005 | EP1495043A2 Retrovirus-based genomic screening |
| 01/12/2005 | EP1494710A2 Diabetes-related immunoglobulin derived proteins, compostions, methods and uses |
| 01/12/2005 | EP1494697A1 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 01/12/2005 | EP1494687A2 Immunomodulatory polymeric antigens for treating inflammatory pathogies |
| 01/12/2005 | EP1494638A1 Compositions and methods for inducing new hair follicle formation and hair growth in a desired orientation |
| 01/12/2005 | EP1494613A2 Potent oncolytic herpes simplex virus for cancer therapy |
| 01/12/2005 | EP1494535A2 Compositions and minimally invasive methods for treating incomplete tissue repair |
| 01/12/2005 | EP1443970A4 Promoters exhibiting endothelial cell specificity and methods of using same |
| 01/12/2005 | EP1401342B1 Apparatus for and methods of preparing sperm |
| 01/12/2005 | EP1385559B1 Chitosan and hydroxy carboxylic acid based porous and non-porous matrices |
| 01/12/2005 | EP1313883A4 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 01/12/2005 | EP1233023B1 Transcription factor and dna thereof |
| 01/12/2005 | EP0996460B1 Treatment of kidney fibrosis with antibodies against integrin alpha-v-beta 6 |
| 01/12/2005 | EP0988860B1 Use of a-glycosylceramides for the manufacture of a therapeutic agent for autoimmune diseases |
| 01/12/2005 | EP0891428B1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/12/2005 | EP0723012B1 Dna coding for phosphoenolpyruvate carboxykinase, recombinant vector containing the same, and transgenic plant |
| 01/12/2005 | EP0627923B1 Therapeutic domains of von willebrand factor |
| 01/12/2005 | EP0568575B1 Test and model for alzheimer's disease |
| 01/12/2005 | CN1564944A Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 01/12/2005 | CN1564869A Plant polynucleotides encoding novel prenyl proteases |
| 01/12/2005 | CN1564866A Self-processing plants and plant parts |
| 01/12/2005 | CN1564864A Process for preparing hematopoietic stem cells |
| 01/12/2005 | CN1564863A Method for production of recombinant proteins in eukaryote cells |
| 01/12/2005 | CN1564829A Antibodies to insulin-like growth factor I receptor |
| 01/12/2005 | CN1564828A Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/12/2005 | CN1564826A Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 01/12/2005 | CN1563392A Agrolbacterium-mediated method for transforming lily from exogenous gene |
| 01/12/2005 | CN1563366A Method for preparing corneal epithelium form epidermis stem cell through fabrication of tissue engineering, and application |
| 01/12/2005 | CN1563365A Method for separating and purifying stem cell of skin epidemis |
| 01/12/2005 | CN1563364A Method for 3D cultivating and inducing stem cell of mesenchyme of bone marrow and chondroblast |
| 01/12/2005 | CN1563363A Method for preparing stem cell of mesenchyme in marrow in large scale |
| 01/12/2005 | CN1563362A Extract of egg cell from human or animal and use for amplifying stem cell as well as induction and differentiation |
| 01/12/2005 | CN1563361A Establishing stem cell series of epidermis on grown milch goat produced in the central Shanxi plain |
| 01/12/2005 | CN1563360A Method for preparing culture medium without blood serum for epidermis stem cell of milch goat in the central Shanxi plain |
| 01/12/2005 | CN1563358A Method for preserving pure line of protoplast of purple laver in ultra low temperature |
| 01/12/2005 | CN1562392A Method for fabricating activated artificial skin tissue in bilayer by using bioreactor |
| 01/12/2005 | CN1561697A Method for establishing lily gene transforming receptor system |
| 01/12/2005 | CN1184320C Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/12/2005 | CN1184315C Death domain containing receptor 5 |
| 01/12/2005 | CN1184309C Method for producing tripterygium alkaloids by plant suspension cultivation cell |
| 01/12/2005 | CN1183962C Preparation capable of mobilization of activity |
| 01/11/2005 | US6841662 Nucleotide sequences coding enzymatic polypeptide for use in the human dietics, cosmetics and therapeutics |
| 01/11/2005 | US6841579 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/11/2005 | US6841542 Transforming growth factor beta (TGF-β) blocking agent-treated stem cell composition and method |
| 01/11/2005 | US6841540 Immunomodulation by genetic modification of dendritic cells and B cells |
| 01/11/2005 | US6841386 Modulating cell differentiation of cultured stem cell; obtain cell, incubate with modulator, monitor adjustment in insulin-like growth factor activity, evaluate stem cell differentiation |
| 01/11/2005 | US6841385 Transcription factor E2F DNA-binding domain inhibitor peptides and their use |